| KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells KK Mahadevan, KM McAndrews, VS LeBleu, S Yang, H Lyu, B Li, ... Cancer Cell 41 (9), 1606-1620. e8, 2023 | 104 | 2023 |
| Marine collagen substrates for 2D and 3D ovarian cancer cell systems F Paradiso, J Fitzgerald, S Yao, F Barry, F Taraballi, D Gonzalez, ... Frontiers in bioengineering and biotechnology 7, 343, 2019 | 42 | 2019 |
| The interaction of the tumor suppressor FAM46C with p62 and FNDC3 proteins integrates protein and secretory homeostasis C Fucci, M Resnati, E Riva, T Perini, E Ruggieri, U Orfanelli, F Paradiso, ... Cell reports 32 (12), 2020 | 38 | 2020 |
| Mechanical studies of the third dimension in cancer: From 2D to 3D model F Paradiso, S Serpelloni, LW Francis, F Taraballi International Journal of Molecular Sciences 22 (18), 10098, 2021 | 37 | 2021 |
| Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer J Dilly, MT Hoffman, L Abbassi, Z Li, F Paradiso, BD Parent, ... Cancer discovery 14 (11), 2135-2161, 2024 | 29 | 2024 |
| Biomimetic scaffolds modulate the posttraumatic inflammatory response in articular cartilage contributing to enhanced neoformation of cartilaginous tissue in vivo G Bauza‐Mayol, M Quintela, A Brozovich, M Hopson, S Shaikh, F Cabrera, ... Advanced Healthcare Materials 11 (1), 2101127, 2022 | 26 | 2022 |
| Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation RA Battista, M Resnati, C Facchi, E Ruggieri, F Cremasco, F Paradiso, ... PLoS One 13 (8), e0201621, 2018 | 23 | 2018 |
| Endosomal escape of polymer‐coated silica nanoparticles in endothelial cells A Parodi, M Evangelopoulos, N Arrighetti, A Cevenini, M Livingston, ... Small 16 (36), 1907693, 2020 | 20 | 2020 |
| Electrospun electroconductive constructs of aligned fibers for cardiac tissue engineering C Mancino, T Hendrickson, LV Whitney, F Paradiso, S Abasi, E Tasciotti, ... Nanomedicine: Nanotechnology, Biology and Medicine 44, 102567, 2022 | 17 | 2022 |
| Improved posterolateral lumbar spinal fusion using a biomimetic, nanocomposite scaffold augmented by autologous platelet-rich plasma JL Van Eps, JS Fernandez-Moure, FJ Cabrera, F Taraballi, F Paradiso, ... Frontiers in bioengineering and biotechnology 9, 622099, 2021 | 9 | 2021 |
| Mechanomimetic 3D scaffolds as a humanized in vitro model for ovarian cancer F Paradiso, S Lenna, SA Gazze, J Garcia Parra, K Murphy, L Margarit, ... Cells 11 (5), 824, 2022 | 7 | 2022 |
| Studying Activated Fibroblast Phenotypes and Fibrosis‐Linked Mechanosensing Using 3D Biomimetic Models F Paradiso, M Quintela, S Lenna, S Serpelloni, D James, S Caserta, ... Macromolecular Bioscience 22 (4), 2100450, 2022 | 4 | 2022 |
| Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma G Romano, F Paradiso, P Li, P Shukla, LN Barger, O El Naggar, JP Miller, ... Cancer immunology research 11 (5), 558-569, 2023 | 2 | 2023 |
| Immunosuppressive potential evaluation of synovial fluid mesenchymal stem cells grown on 3D scaffolds as an alternative source of MSCs for osteoarthritis cartilage studies F Paradiso, S Lenna, R Isbell, MF Garcia Garza, M Williams, C Varner, ... Frontiers in Biomaterials Science 1, 989708, 2022 | 2 | 2022 |
| Osteogenesis in the presence of chemotherapy: A biomimetic approach AA Brozovich, S Lenna, F Paradiso, S Serpelloni, P McCulloch, B Weiner, ... Journal of Tissue Engineering 13, 20417314221138945, 2022 | 2 | 2022 |
| Abstract B092: CDK8 and CXCL2 remodel the tumor microenvironment to contribute to KRASG12D small molecule inhibition resistance in pancreatic ductal … KM McAndrews, KK Mahadevan, B Li, AM Sockwell, SJ Morse, PJ Kelly, ... Cancer Research 84 (2_Supplement), B092-B092, 2024 | 1 | 2024 |
| Comparison between cancellous trabecular and cortical specimens from human lumbar spine samples as an alternative source of mesenchymal stromal cells S Lenna, A Brozovich, T Hirase, F Paradiso, BK Weiner, F Taraballi Stem Cells and Development 31 (21-22), 672-683, 2022 | 1 | 2022 |
| CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRASG12D inhibition in pancreatic ductal adenocarcinoma KM McAndrews, KK Mahadevan, B Li, AM Sockwell, SJ Morse, PJ Kelly, ... bioRxiv, 2025.01. 29.635543, 2025 | | 2025 |
| Systemic Cisplatin Does Not Affect the Bone Regeneration Process in a Critical Size Defect Murine Model AA Brozovich, S Lenna, C Brenner, S Serpelloni, F Paradiso, P McCulloch, ... ACS Biomaterials Science & Engineering 10 (3), 1646-1660, 2024 | | 2024 |
| CDK8 and CXCL2 remodel the tumor microenvironment to contribute to KRASG12D small molecule inhibition resistance in pancreatic ductal adenocarcinoma KM McAndrews, KK Mahadevan, B Li, AM Sockwell, SJ Morse, PJ Kelly, ... CANCER RESEARCH 84 (2), 2024 | | 2024 |
Stefano SerpelloniPolitecnico di Milano, Houston Methodist HospitalE-mailová adresa ověřena na: houstonmethodist.org